首页> 美国卫生研究院文献>Journal of Diabetes Science and Technology >Meeting Report: The Fourth Artificial Pancreas Workshop: Testing and Adoption of Current and Emerging Technologies
【2h】

Meeting Report: The Fourth Artificial Pancreas Workshop: Testing and Adoption of Current and Emerging Technologies

机译:会议报告:第四届人工胰腺研讨会:最新技术的测试和采用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

On July 6 and 7, 2016 the Fourth Artificial Pancreas Workshop: Testing and Adoption of Current and Emerging Technologies was held on the National Institutes of Health (NIH) Campus at the Lister Hill Auditorium. The meeting was sponsored by a group of governmental organizations and NGOs, listed in Appendix A. This was a very timely meeting as the artificial pancreas appears to be growing from academic studies to commercial projects. The first artificial pancreas may be marketed within 12 months and a few may be approved within 24 months. The NIH, the FDA, the JDRF, Helmsley Trust, Diabetes Technology Society, and other agencies, funders, and organizations have been strongly supportive of advancing artificial pancreas technology and usability, and thus the proceedings from this conference should be of exceptional interest to the diabetes technology community.
机译:2016年7月6日至7日,第四次人工胰腺研讨会:最新技术的测试和采用在美国国立卫生研究院(NIH)校园的李斯特山礼堂举行。该会议由附录A中列出的一组政府组织和非政府组织赞助。这是一次非常及时的会议,因为人造胰腺似乎正从学术研究发展到商业项目。首批人造胰腺可在12个月内上市,少数可在24个月内获批。 NIH,FDA,JDRF,Helmsley Trust,糖尿病技术协会以及其他机构,资助者和组织一直大力支持推进人造胰腺技术和可用性,因此,本次会议的议事应该引起特别关注。糖尿病技术社区。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号